๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunotoxin therapy for primary malignant brain tumors

โœ Scribed by Ki-Uk Kim; Daniel A. Vallera; Hsiao-Tzu Ni; Kwan H. Cho; Stephen R. Spellman; Walter C. Low; Walter A. Hall

Book ID
117550810
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
148 KB
Volume
1247
Category
Article
ISSN
0531-5131

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Radiosurgery for primary malignant brain
Radiosurgery for primary malignant brain tumors
โœ Eben Alexander III; Jay S. Loeffler ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB ๐Ÿ‘ 2 views

Despite the ability of surgery, radiotherapy, and chemotherapy to prolong survival in patients with glioblastoma multiforme (GBM), most patients succumb to their disease, usually as a result of local tumor persistence or recurrence. Stereotactic radiosurgery (SRS) allows a substantial increase in to

Immunotoxin Therapy for CNS Tumor
Immunotoxin Therapy for CNS Tumor
โœ Edward Rustamzadeh; Walter C. Low; Daniel A. Vallera; Walter A. Hall ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Springer US ๐ŸŒ English โš– 141 KB
Radiotherapy of primary malignant brain
Radiotherapy of primary malignant brain tumors
โœ David A. Larson; William M. Wara ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 2 views

Radiotherapy is usually recommended for patients with a primary malignant brain tumor. The foundation for its use is grounded on the results of randomized trials for malignant gliomas which have demonstrated a relationship between survival and external beam radiation dose. Although similar trials ha